Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (151 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Oct 2022 – 20 Aug 2026, limited by UTI Gold ETF Fund of Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | UTI Gold ETF Fund of Fund | Gold |
|---|---|---|
| 31 Oct 2022 | ₹100.00 | ₹100.00 |
| 24 Feb 2023 | ₹110.17 | ₹110.53 |
| 20 Jun 2023 | ₹116.69 | ₹116.79 |
| 13 Oct 2023 | ₹114.69 | ₹114.48 |
| 06 Feb 2024 | ₹122.34 | ₹122.46 |
| 01 Jun 2024 | ₹141.78 | ₹141.78 |
| 25 Sep 2024 | ₹147.65 | ₹147.26 |
| 18 Jan 2025 | ₹155.08 | ₹154.20 |
| 14 May 2025 | ₹182.49 | ₹181.77 |
| 07 Sep 2025 | ₹206.68 | ₹205.07 |
| 01 Jan 2026 | ₹257.81 | ₹255.66 |
| 26 Apr 2026 | ₹288.98 | ₹286.70 |
| 20 Aug 2026 | ₹300.48 | ₹298.13 |
| Metric | UTI · Direct NAV ₹29.97 High risk ★★★★★ | Category median FoF Domestic · 151 funds |
|---|---|---|
| +57.23% | +8.79% | |
| +37.62% | +14.76% | |
| — | +11.89% | |
| — | +12.34% | |
| +33.55% | +11.30% | |
| +37.74% | — | |
| +35.02% | +13.06% | |
| — | +10.96% | |
| — | +10.76% | |
| Risk | ||
| 20.58% | 15.95% | |
| 1.51 | 0.81 | |
| 2.15 | 1.14 | |
| -23.57% | -19.45% | |
| Gold | — | |
| +1.84% | +1.81% | |
| 0.94 | 0.94 | |
| 100.4% | 98.0% | |
| 99.0% | 93.1% | |
| 0.09% | 0.17% | |
| ₹614.78Cr | ₹228.08Cr | |
| 1.00% | — | |
| None | — | |
| ₹25 | — | |
| ₹5.00K | — | |
| — | 11% | |
| Sharwan Kumar Goyal | — | |
| 31 Oct 2022 | — | |
| — | — | |
| — | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.